
3rd AnnualInvitation Only
Multiple Myeloma
USFocus Meeting 2027
Two days, 48 people, one room.
August 13 to 14, 2027
Sheraton Boston Hotel, Boston, MA
Dates
August 13-14, 2027
Two-day program
Venue
Sheraton Boston Hotel
Boston, MA
Audience
48 by invitation
24 KOLs & 24 fellows
Format
8 sessions · 24 talks
Plenary, panels + case sessions
A Curated Room: The People Shaping Practice
Now in its third year, this invitation-only meeting convenes a deliberately small faculty: 24 leading multiple myeloma KOLs alongside 24 hand-selected fellows and junior faculty, the clinicians defining today’s standards and the ones who will define the next decade’s, in one room for two days.
The science follows myeloma across its full course: precursor states and early intervention, MRD and risk-adapted therapy, sequencing decisions in early and late relapse, and the other plasma cell disorders often left off the program. Every session pairs expert talks with a moderated panel and a case presentation, sustained, close-quarters engagement rather than a lecture hall.
Precursor StatesMRD & Risk-Adapted TherapyEarly & Late RelapseOther Plasma Cell DisordersDiagnosis & MonitoringSupportive Care
Meeting Co-Chairs
Listed alphabetically by surname

Shaji Kumar
Mayo Clinic, Rochester, MN

Noopur Raje
Massachusetts General Hospital, Boston, MA
Faculty Drawn From
Mayo Clinic · Dana-Farber · Massachusetts General · Memorial Sloan Kettering · MD Anderson and other leading US cancer centers
48
Invited attendees only, sustained access, not a crowd
1:1
KOLs to rising faculty, a hand-picked balance in every session
21
Established meetings across the US and Europe, a proven platform
Multiple Myeloma US Focus Meeting 2027
Confirmed Faculty
Listed alphabetically by surname
Andrew Branagan
Massachusetts General Hospital, Boston, MA
Natalie Callander
University of Wisconsin School of Medicine and Public Health, Madison, WI
Diana Cirstea
Massachusetts General Hospital, Boston, MA
Joselle Cook
Mayo Clinic, Rochester, MN
Amandeep Godara
Huntsman Cancer Institute, Salt Lake City, UT
Wilson Gonsalves
Mayo Clinic, Rochester, MN
Murali Janakiram
City of Hope, Duarte, CA
Nisha Joseph
Emory University, Atlanta, GA
Prashant Kapoor
Mayo Clinic, Rochester, MN
Gurbakhash Kaur
Icahn School of Medicine at Mount Sinai, New York, NY
Shaji Kumar
Mayo Clinic, Rochester, MN
Nelson Leung
Mayo Clinic, Rochester, MN
Shonali Midha
Dana-Farber Cancer Institute, Boston, MA
Meera Mohan
UT MD Anderson Cancer Center, Houston, TX
Omar Nadeem
Dana-Farber Cancer Institute, Boston, MA
Ajay Nooka
Emory University, Atlanta, GA
Benjamin Puliafito
Massachusetts General Hospital, Boston, MA
Noopur Raje
Massachusetts General Hospital, Boston, MA
Ashley Rosko
The Ohio State University Comprehensive Cancer Center, Columbus, OH
Mehmet Samur
Dana-Farber Cancer Institute, Boston, MA
Raphael Szalat
Boston Medical Center, Boston, MA
Andrew Yee
Massachusetts General Hospital, Boston, MA
Saurabh Zanwar
Mayo Clinic, Rochester, MN
Further faculty to be announced
Eight Sessions
Proposed Faculty by Session
15 min
5 min
30 min
20 min
65 min
Diagnosis & Monitoring
Moderator
Raphael SzalatBoston Medical Center, Boston, MA
Mehmet SamurDana-Farber Cancer Institute, Boston, MA
Noopur RajeMassachusetts General Hospital, Boston, MA
Precursor States
Moderator
Omar NadeemDana-Farber Cancer Institute, Boston, MA
Shaji KumarMayo Clinic, Rochester, MN
Natalie CallanderUniversity of Wisconsin School of Medicine and Public Health, Madison, WI
MRD
Moderator
Nisha JosephEmory University, Atlanta, GA
Meera MohanUT MD Anderson Cancer Center, Houston, TX
Joselle CookMayo Clinic, Rochester, MN
Other PCDs
Moderator
Andrew BranaganMassachusetts General Hospital, Boston, MA
Amandeep GodaraHuntsman Cancer Institute, Salt Lake City, UT
Nelson LeungMayo Clinic, Rochester, MN
Early Relapse
Moderator
Murali JanakiramCity of Hope, Duarte, CA
Benjamin PuliafitoMassachusetts General Hospital, Boston, MA
Late Relapse
Moderator
Saurabh ZanwarMayo Clinic, Rochester, MN
Andrew YeeMassachusetts General Hospital, Boston, MA
Shonali MidhaDana-Farber Cancer Institute, Boston, MA
Risk-Adapted Therapy
Moderator
Prashant KapoorMayo Clinic, Rochester, MN
Wilson GonsalvesMayo Clinic, Rochester, MN
Ajay NookaEmory University, Atlanta, GA
Supportive Care & Unclear
Moderator
Diana CirsteaMassachusetts General Hospital, Boston, MA
Gurbakhash KaurIcahn School of Medicine at Mount Sinai, New York, NY
Ashley RoskoThe Ohio State University Comprehensive Cancer Center, Columbus, OH
Partnership Opportunities Now Open
Bespoke engagement packages for a closed, invitation-only audience
Request the Prospectus →

Your Point of Contact
Tania Lifanova
Account Executive, MD Education
tania.lifanova@md-education.com
